2023 Crohn's and Colitis Conference

May 20, 2023

Target Audience

This is a program designed for physicians, nurses, pharmacists, nurse practitioners and physician assistants, allied health professionals, interns, residents, fellows and community partners specializing in Gastroenterology and Hepatology, Family Practice, Internal Medicine, Primary Care, General and Colorectal Surgery and Basic scientists.

Learning Objectives

Participants who engage in this educational intervention will be able to: 

  • Describe novel and emerging therapies in the treatment of ulcerative colitis and Crohn's disease and how they are best positioned to optimize disease outcomes.
  • Understand the different mechanisms of action for novel and emerging therapies in the treatment of ulcerative colitis and Crohn's disease and the potential complications associated with these therapies.
  • Identify the patient characteristics that allow for therapy cessation and/or de-escalation in patients with ulcerative colitis and Crohn's disease.

 

 

Additional information

Contact

Name: 
Kari Warren
Phone Number: 
+1 (414) 955-6850
Email: 
kwarren@mcw.edu
Course summary
Available credit: 
  • 5.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 5.25 Hours of Participation
    Hours of Participation credit.
Course opens: 
01/01/2023
Course expires: 
08/20/2023
Event starts: 
05/20/2023 - 7:23am CDT
Event ends: 
05/20/2023 - 2:00pm CDT
Cost:
$0.00
Add to calendar: 

    

   Crohn's and Colitis Foundation Conference

A Patient and Provider Point of Care Conference

 

May 20,2023

7:30-7:45 

Registration and Continental Breakfast

 Pediatric IBD: Lets Start at the Very Beginning
7:45-8:00Welcome and Introductions- Dr. Daniel Stein/Crohn's & Colitis Foundation
8:00-8:45Genetics and Inflammatory Bowel Disease- Dr. Subra Kugathasan
8:45-9:15Early Onset Inflammatory Bowel Disease- Dr. Abdul ElKadri
9:15-9:20Questions
9:20-9:30BREAK
 IBD: It's not just for the Gastroenterologists!
9:30-10:00When to Call a Crohn's Surgeon?- Dr. Carrie Peterson
10:00-10:30Dermatologic Manifestations of IBD- Dr. Gretchen Roth
10:30-10:35Questions
 The Future of IBD Therapy
10:35-11:05New Therapies in Crohn's Disease- Dr. Amir Patel
11:05-11:25New Therapies in Ulcerative Colitis- Dr. Daniel Stein
11:25-12:05Cardiovascular and Thrombotic Complications in IBD- The Jack Effect-Fact or Fiction- Dr. Preetika Sinh
12:05-12:10Questions
12:10-12:30Break
12:30-1:00"Working Lunch" Open Case Discussion "Ask the Experts"
1:00-1:30Salt's Role in IBD- Dr. David Binion
1:30-2:00Closing Remarks/Summary- Dr. Daniel Stein

 

 

 

 

 

Medical College of Wisconsin
Milwaukee, WI 53226
United States

LOCATION-H1400 Bolger Auditorium

Medical College of Wisconsin

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
 
Preetika Sinh, MD
Abdul ElKardi, MD
Carrie Peterson, MD
Subra Kugathasan, MD
 
The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.

 

Daniel Stein, MD

Amir Patel, MD

Gretchen Roth, MD

David Binion, MD

  

Name

Company

Role

Current Relationship

Received

Daniel Stein, MD

Abbvie

Speaker/Teacher

 

Current

Honorarium

 

Abbvie

Review Panel

Current

Consulting Fee

 

Bristol Myers Squibb

Speaker/Teacher

Current

Honorarium

 

Janssen/Pfizer, Takeda

 Speaker

Relationship ended

Honorarium

 

Name

Company

Role

Current Relationship

Received

Amir Patel, MD

Abbvie

Speaker/Teacher

 

Current

Honorarium

 

Bristol Myers Squibb

Speaker/Teacher

Current

Honorarium

 

Takeda

 Speaker/Teacher

Current

Honorarium

   

Name

Company

Role

Current Relationship

Received

Gretchen Roth, MD

Abbvie

Consultant

Ended

Consultant Fee

 

Novartis

Speaking/Teacher

Educational session for third party (Physician Education Resource) funded by education grant from Novartis

Ended

Honorarium

 

Name

Company

Role

Current Relationship

Received

David Binion, MD

Merk

Researcher

 

Current

Research Funding

 

Takeda

Researcher

Current

Research Funding

 

Abbvie

Researcher

Current

Research Funding

 

Sanfio

Research

 

FDA registration trial

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 5.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 5.25 hours of participation for continuing education for allied health professionals. 

 

Available Credit

  • 5.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 5.25 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.

Registration scams:

Registration for courses managed by MCW Office of Continuing Professional Development can only be completed through our portal at https://ocpe.mcw.edu/. Course registrations made through other sites cannot be honored. MCW Office of Continuing Professional Development is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

 

Please report any unauthorized websites or solicitations for registrations to cme@mcw